← Analysis page  ·  Pieter Slegers hub  ·  Research hub

Actionable insights — Portfolio Update: July 2026

Separating a commodity price cycle from a durable advantage, using two valuations that fail differently, building a return from two disclosed inputs, and treating volatility as an input for a company that buys its own shares.
2026-JUL-12 · Compounding Quality (Substack) · Pieter Slegers / Team Compounding Quality · read ↗ · full analysis · transcript
How to read this page: the standout method here is comparative — the same cyclical reasoning is applied to memory chips and to excess-and-surplus insurance and produces opposite conclusions. Each insight is a step actually taken in the issue, written so it can be rerun elsewhere. Written post, so no timestamps.

1. Read a commodity peak backwards: from the losses that caused it

The repeatable method
  1. Establish whether the product is differentiated. The test is a question, not a ratio: could this company lose money because customers demanded lower prices? If yes, it is a commodity and its profits are a function of supply and demand, not of quality.
  2. Trace the supply history. Extreme current profits usually follow a period of losses severe enough to have stopped capacity being built — find that period and quantify it.
  3. Find the previous margin peak and look at what happened to margins, and then to the share price, in the following one to two years.
  4. Compare today's margin with that prior peak. If it is higher, the invitation to competitors is stronger, not weaker.
  5. Ask what the current price implies: is the market capitalising peak profits as if they were normal? If so, the bet you are being offered is "no mean reversion," and you can decline it without shorting.
Here: MU — 2023-24 losses (CEO Sumit Sadana on customers "being very aggressive with pricing") stopped fab investment; AI demand then hit starved supply; margins now exceed the 2018 peak, "and Micron's stock went down the year thereafter." Grantham: "If you make abnormal profits, you will receive competition. If you make obscene profits, you'll get ferocious competition." Conclusion: "that's not a bet that I want to make."
Watch for

2. Apply the same cycle logic to your own holdings — and let a cost advantage change the answer

The repeatable method
  1. When you make a cyclical argument against something, immediately ask which of your own positions is in an equivalent price cycle.
  2. For each, identify whether there is a structural cost or capability advantage that survives the down-leg. Commodity cycle plus no advantage is a pass; commodity cycle plus a durable low-cost position is an entry.
  3. Confirm the mechanism explicitly: weaker competitors lose money, withdraw capacity, and prices recover — with your holding still standing.
  4. Then test whether the market is pricing the down-leg as permanent. That, not the cycle itself, is the opportunity.
  5. Write both cases side by side so the asymmetry is visible and can be challenged.
Here: KNSL — "the E&S market is 'softening'… Much like with the memory business, that usually leads to companies losing money, competition going down, and prices going back up. But Mr. Market is pricing Kinsale like the soft market will continue forever." The advantage that separates it from MU: own-built technology, small-account focus, in-house underwriting and claims.
Watch for

3. Run a relative multiple and a reverse DCF, and require both to agree

The repeatable method
  1. Compare the forward multiple with the company's own long-run average, not with a sector or index figure. Express the gap as a percentage.
  2. Separately, run a reverse DCF: at today's price and a 10% required return, what annual free-cash-flow growth is implied?
  3. Compare that implied rate with the growth actually delivered over five and ten years.
  4. Act when both readings point the same way. When they disagree, the disagreement is the finding — one of the two inputs is wrong.
  5. State both numbers in the write-up so a reader can reject either independently.
Here: KNSL — forward PE "less than half its historical average" and a reverse DCF needing 3.3%. IPAR — 23x against ~34x, "an undervaluation of almost 40% (!)" and 3.3%. AMP is the instructive exception: "trading right around its historical average Forward P/E," so the multiple says nothing — but the reverse DCF needs only 2%, the lowest bar of the three, and the case rests there.
Watch for

4. Underwrite the whole portfolio the way you underwrite one stock

The repeatable method
  1. Aggregate the book into three or four numbers: weighted forward multiple, expected revenue growth, and the discount or premium versus the index.
  2. Build the expected return from disclosed inputs — assume owner's earnings grow at the revenue rate (deliberately conservative), then assume a re-rating to a stated target multiple.
  3. Report the sum, not a target. The reader should be able to disagree with one input and redo it.
  4. Add a growth-of-intrinsic-value figure so the reader can see the portfolio's engine independently of its price.
  5. Revisit the same four numbers each period; the trend in them is more informative than any single reading.
Here: forward PE 17.1x, expected revenue growth +6.8%, "15% (!) cheaper than the S&P 500," intrinsic value compounding "nearly 20% (!) per year" — and the sum: grow owner's earnings at 6.8% and re-rate to 20x for a 10% annual return. "In other words, the expectations for our businesses are very low right now."
Watch for

5. For a company buying back stock, treat share-price volatility as an input, not a cost

The repeatable method
  1. Identify holdings that retire a meaningful share of their own equity each year.
  2. For these, invert the usual reading: a lower price means the same buyback budget retires more shares, permanently increasing each remaining holder's claim.
  3. Confirm management actually buys into weakness rather than steadily, and check the share count trend rather than the dollars spent.
  4. Verify the buyback is not merely absorbing stock-based compensation.
  5. Adjust your own behaviour accordingly: a drawdown in a cannibal stock is a reason to hold or add, not to reassess.
Here: AMP — "Since we bought Ameriprise, the price has been volatile… That's good news for a cannibal stock like Ameriprise. Management has had a lot of chances to keep reducing the share count." Two weeks earlier the same name was described as returning over 8% a year through dividends and buybacks combined.
Watch for

6. Keep a divergence case study on hand for the years the price is wrong

The repeatable method
  1. Collect examples of a share price falling for a year or more while the underlying free cash flow rose — ideally in a company you do not own, so the example is not self-serving.
  2. Identify the fear that caused the divergence, and whether it eventually proved true, partly true, or false.
  3. Use the case to set your own expectations of duration: divergences of two to three years are normal, not anomalous.
  4. Convert it into a monitoring rule — track the cash flow line, not the price line, and define in advance what deterioration would count as a broken thesis.
Here: ABBV, explicitly not owned — "the price declined all through 2018 because of fear over some of its drugs losing patent protection. In the meantime the Free Cash Flow kept increasing. And over the next few years, the stock caught up and more than doubled."
Watch for

7. Pick a single public proxy for the factor you are exposed to, and watch it

The repeatable method
  1. Choose one liquid, well-understood security that behaves like the style you run, so you can observe the factor without buying a factor index.
  2. Track it over two windows — a long one for where you have been, a short one for any turn.
  3. Read a divergence between the windows as tentative evidence, and say so; do not size a position on it.
  4. Pair the proxy with a breadth reading (the riskiest versus the safest cohorts relative to the index) so a single stock is not carrying the inference.
Here: BRK.B — behind the S&P 500 over the past year, ahead over the past month, read as "we might be starting to see a rotation back into quality," with the claim kept deliberately provisional.
Watch for

8. Distinguish the two kinds of speculation running at the same time

The repeatable method
  1. Separate the crowd's enthusiasms into loss-makers priced on possibility and over-earners priced on a peak. They fail differently and on different timetables.
  2. For the loss-makers, the question is funding and dilution; for the over-earners, it is capacity and mean reversion.
  3. Note which of your own holdings would be affected by each unwinding, and how the two would interact.
  4. Resist a single "bubble" label — the two groups are not the same trade and will not reverse together.
Here: loss-makers — SpaceX, OpenAI, Anthropic, Stripe, which "lose money every single month"; over-earners — Micron, Western Digital, SanDisk, "up +200 to +700% this year" and "currently making too much money." The post keeps the two diagnoses explicitly separate: "a different kind of problem."
Watch for

Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.